Skip to main content Accessibility help
×
Home

Longevity in the 21st Century

  • R. C. Willets (a1), A. P. Gallop, P. A. Leandro, J. L. C. Lu, A. S. Macdonald, K. A. Miller, S. J. Richards, N. Robjohns, J. P. Ryan and H. R. Waters...

Abstract

The main objective of this paper is to offer a detailed analysis of mortality change in the United Kingdom at the beginning the 21st century. Starting from an exploration of 20th century mortality trends, focusing in particular on the 1990s, underlying forces driving trends in longevity are discussed. These include the ‘cohort effect’ and the ‘ageing of mortality improvement’. International mortality statistics and trends are also analysed. The pace of medical advances is discussed, with specific focus on research into the ageing process and a potential treatment for cardiovascular disease. The paper also discusses the potential threat from infectious diseases.

The analysis of underlying trends suggests that life expectancy in retirement in the U.K. is likely to increase rapidly in the early part of the 21st century. Some scientists are also claiming that we will be seeing the fruits of anti-ageing research within just a few decades.

A core theme of the paper is that future projections should be grounded in as good an understanding of the past as possible. Different methods for projecting future rates of mortality are discussed, and it is noted that emphasis should be placed on the uncertainty surrounding projections.

The financial impact of using different assumptions for future mortality is explored. Significant differences in the cost of an annuity or pension arise from the use of the various projection bases.

Life assurance companies have already declared significant losses as a result of strengthening reserves on annuity portfolios. Taken together, future increases in life expectancy, increasing awareness of the risk of providing longevity insurance, changes in legislation and shortages in market capacity and capital, may well lead to worsening annuity rates.

It is difficult to assess the precise impact of future changes in life expectancy on final salary pension schemes. There is a lack of readily available information on the mortality assumptions being used in practice. It is therefore suggested that more disclosure in this area would be helpful. Employers sponsoring final salary schemes are making promises to their employees that extend up to 70 or 80 years into the future. Actuaries should be clear in spelling out to employers and trustees the nature of the risks behind the promises they are making. Future scheme design should reflect the possibility of substantial increases in life expectancy.

An over-riding implication of the anticipated increases in life expectancy is that people will remain in work for longer in the future. The age at which people retire will inevitably have to increase, and this trend will necessarily drive changes in all aspects of our society. As actuaries we have a vital role in helping to inform the wider debate.

Copyright

References

Hide All
Ainslie, R. (2000). Annuity and insurance products for impaired lives. Paper presented to the Staple Inn Actuarial Society.
Austad, S.N. (1997). Why we age. John Wiley & Sons, New York.
Beeching, N.J., Dance, D.A.B., Miller, A.R.O. & Spencer, R.C. (2002). Biological warfare and bioterrorism. British Medical Journal, 324, 336339.
Benjamin, B. (1982). The span of life. Journal of the Institute of Actuaries, 109, 319357.
Benjamin, B. & Soliman, A.S. (1993). Mortality on the move: methods of mortality projection. City University.
Bird, S.M., Goldberg, D.J. & Hutchinson, S.J. (2001a). Projecting severe sequelae of injection-related hepatitis C virus epidemic in the U.K. - Part 1. Journal of Epidemiology andBiostatistics, 6, 3, 243265.
Bird, S.M., Goldberg, D.J. & Hutchinson, S.J. (2001b). Projecting severe sequelae of injection-related hepatitis C virus epidemic in the U.K. - Part 2. Journal of Epidemiology and Biostatistics. 6, 3, 267277.
Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S. & Wright, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science, 279(5349), 349352.
Boelle, P.Y., Thomas, G., Valleron, A.J., Cesbron, J.Y. & Will, R. (2003). Modelling the epidemic of variant Creutzfeldt-Jakob disease in the U.K. based on age characteristics: updated, detailed analysis. Statistical Methods in Medical Research, 12, 3, 221233.
Brackenridge, R.D.C. & Elder, W.J. (1998). Medical selection of life risks. Fourth edition. Macmillan Ltd.
B.B.C. News Online (2001). France's glamorous grannies battle time. BBC News, 27 July 2001. Available at http://news.bbc.co.uk/1/hi/programmes/from_our_own_correspondent/1460770.stm
B.B.C. News Online (2003a). Dolly the cloned sheep dies. BBC News, 14 February 2003. Available at http://news.bbc.co.uk/1/hi/sci/tech/2764363.stm
B.B.C. News Online (2003b). Secret of cancer's ‘eternal youth’. BBC News, 1 February 2003. Available at http://news.bbc.co.uk/1/hi/health/2709151.stm
B.B.C. News Online (2003c). Italians flock to pensions protest. BBC News, 6 December 2003. Available at http://news.bbc.co.uk/1/hi/world/europe/3296917.stm
British Heart Foundation (2003). Coronary heart disease statistics 2003. www.heartstats.org
Caselli, G. (1996). Future longevity among the elderly. In Health and mortality among elderly populations. Edited by Caselli, Graziella and Lopez, Alan D.. Clarendon Press, Oxford.
Center for Strategic and International Studies and Watson Wyatt Worldwide (2003). The 2003 aging vulnerabiliy index. www.csis.org
CMI Bureau (1999). CMI report number 17. CMI Bureau.
CMI Bureau Mortality Sub-Committee (2002). Working paper 1: an interim basis for adjusting the ‘92 series’ mortality projections for cohort effects. CMI, London.
Cousens, S., Everington, D., Ward, H.J.T., Huillard, J., Will, R.G. & Smith, P.G. (2003). The geographical distribution of variant Creutzfeldt-Jakob disease cases in the U.K.: what can we learn from it? Statistical Methods in Medical Research, 12, 3, 235246.
Critical Illness Trends Research Group (2003). Presentation to the 2003 Healthcare Conference, Warwick.
Crowcroft, N.S. & Catchpole, M. (2002). Mortality from methicillin resistant Staphylococcus aureus in England and Wales: analysis of death certificates. British MedicalJournal, 325, 13901391.
Cruijsen, H. & Ding, H. (2002). Latest national mortality forecasts in Europe. Presentation to the Eurostat working party on demographic projections 16-17 September 2002.
De Grey, A.D.N.J. (2003). The foreseeability of real anti-aging medicine: focusing the debate. Experimental Gerontology, 38, 927934.
Department of Health (1999). Saving lives: our healthier nation. H.M.S.O., London.
Department of Health (2003). Chief Executive's report to the NHS. Department of Health Publications, London.
Deuffic, S., Poynard, T. & Valleron, A.J. (1999). Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe. Journal of Viral Hepatitis, 6, 5, 411413.
Donkin, A., Goldblatt, P. & Lynch, K. (2002). Inequalities in life expectancy by social class, 1972-1999. Health Statistics Quarterly, 15, 515.
Doll, R., Peto, R., Wheatley, K., Gray, R. & Sutherland, I. (1994). Mortality in relation to smoking: 40 years' observations on male British doctors. British Medical Journal, 309, 901911.
Dormont, D. (2002). Prion diseases: pathogenesis and public concerns. F.E.B.S. letters, 529, 1721.
Drucker, P. (1999). Innovate or die. The Economist. 25/9/1999.
Eurocare Working Group (2003). Eurocare-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 14, Suppl 5, 128149.
Faculty of Actuaries and Institute of Actuaries Pensions Board (2000). Review of the Minimum Funding Requirement. A report to the Secretary of State for Social Security.
Faculty of Actuaries and Institute of Actuaries Pensions Board (2001). Review of the MFR basis. A letter to the Department of Work and Pensions.
Flynn, M.A., Weaver-Osterholtz, D., Sharpe-Timms, K.L., Allen, S. & Krause, G. (1999). Dehydroepiandrosterone replacement in aging humans. Journal of Clinical Endocrinology and Metabolism, 84, 15271533.
Franciscus, A. (2003). Considering HCV treatment? — Know your genotype and viral load. Hepatitis C Support Project — HCV Advocate June 2003. www.hcvadvocate.org
Food Standards Agency (2002). F.S.A. consumer attitudes to food survey — 2001. www.food.gov.uk
Friedman, D.B. & Johnson, T.E. (1988). A mutation in the age-1 gene in caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics, 118(1), 7586.
Ghani, A.C., Ferguson, N.M., Donnelly, C.A. & Anderson, R.M. (2003). Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the U.K. Proceedings: Biological Sciences, 270, 1516, 689698.
Government Actuary's Department (1995). National population projections 1992-based. H.M.S.O., London.
Government Actuary's Department (2001). National population projections: review of methodology for projecting mortality. Government Actuary's Department, London.
Government Actuary's Department (2002). National population projections 2000-based. H.M.S.O., London.
Government Actuary's Department (2003a). Interim life tables 2000-02. www.gad.gov.uk
Government Actuary's Department (2003b). Government Actuary's quinquennial review of the National Insurance Fund as at April 2000. H.M.S.O.
Government Actuary's Department (2003c). ‘2002-based’ U.K. population projections. www.gad.gov.uk
Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W. & Weinberg, R.A. (1999). Creation of human tumour cells with defined genetic elements. Nature. 400(6743), 464468.
Hawkes, N. (2003). £1 ‘superpill’ could cut heart attacks by 80%. The Times, June 27, 2003. Available at http://www.timesonline.co.uk/article/0%2c%2c2-727079%2c00.html
Hayflick, L. & Moorhead, P. (1961). The serial cultivation of human diploid cell strains. Experimental Cell Research, 25, 585621.
Heath, P.T. & Breathnach, A.S. (2002). Treatment of infections due to resistant organisms. British MedicalJournal, 61, 231245.
Held, G. (2002). Plastic omega. Paper presented to the Society of Actuaries symposium: ‘Living to 100 and beyond: survival at advance ages’.
Hewitt Bacon & Woodrow (2004). Pension scheme deficits halved as equity markets deliver positive returns for 2003. www.hewittbaconwoodrow.co.uk
HM Treasury/Inland Revenue (2003). Simplifying the taxation of pensions: the Government's proposals. H.M.S.O.
Horan, M. (1998). Advances in understanding the concept of biological ageing. In Increasing longevity: medical, social and political implications. Edited by Tallis, Raymond. Royal College of Physicians.
Housholder, J. (1998). From smokers to ex-smokers. The Cologne Re Risk Insights, Vol. 2, No. 3, 47.
Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Lamming, D.W., Lavu, S., Wood, J.G., Zipkin, R.E., Chung, P., Kisielewski, A., Zhang, L.L., Scherer, B. & Sinclair, D.A. (2003). Small molecule activators of sirtuins extend saccharomyces cerevisiae lifespan. Nature, 425(6954), 191196.
Huillard D'Aignaux, J.N., Cousens, S.N. & Smith, P.G. (2003). The predictability of the epidemic of variant Creutzfeldt-Jakob disease by back-calculation methods. Statistical Methods in Medical Research, 12, 3, 203220.
Human Mortality Database (2003). www.mortality.org
JP Morgan (2003). U.K. insurance: annuities — the die is cast. JP Morgan European Equity Research, 30 October 2003.
Kaku, M. (1998). Visions: how science will revolutionize the 21st century. Bantam Books.
Kannisto, V. (1994). Development of oldest-old mortality, 1950-1990: Evidence from 28 developed countries. University Press of Southern Denmark.
Kirkwood, T.B.M. (1998). Genetics and the future of human longevity. In Increasing longevity: medical, social and political implications. Edited by Tallis, Raymond. Royal College of Physicians.
Kirkwood, T.B.L. (2004). Expectations of life. British Actuarial Journal, 10, 75100.
La Vecchia, C., Lucchini, F., Franceschi, S., Negri, E. & Levi, F. (2000). Trends in mortality from primary liver cancer in Europe. European Journal of Cancer, 36, 7, 909915.
Larkin, M. (1998). DHEA: will science confirm the headlines? The Lancet, 352(9123).
Law, M.R., Wald, N.J., Morris, J.K. & Jordan, R.E. (2003). Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. British Medical Journal, 326, 14271431.
Law, M.R., Wald, N.J. & Rudnicka, A.R. (2003). Quantifying the effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. British Medical Journal, 326, 14231427.
Liddle, B.J. & Jennings, R. (2001). Influenza vaccination in old age. Age and Ageing, 30, 385389.
Lucas, G.M. (2003). Taking HAART to heart: antiretroviral toxicity. The Hopkins HIV Report - March 2003.
Macdonald, A.S., Waters, H.R. & Wekwete, C.T. (2003). A model for coronary heart disease and stroke with applications to critical illness insurance underwriting I: The model. Submitted for publication. Available at http://www.ma.hw.ac.uk/ams.html
MacMinn, R. (2003). International mortality comparisons. Presentation to the Society of Actuaries, Vancouver. www.journalofriskandinsurance.org
Marmot, M., Bosma, H., Hemingway, H., Brunner, E. & Stansfield, S. (1997). Contribution of job control and other risk factors to social variations in coronary heart disease incidence. The Lancet, 350, 235239.
Marra, M.A., Jones, S.J.M., Astell, C.R.et al. (2003). The genome sequence of the SARS-associated coronavirus. Science, 300, 1399.
Medina, J. (1996). The clock of ages: why we age — how we age — winding back the clock. Cambridge University Press.
Morales, C.P., Holt, S.E., Ouelette, M., Kaur, K.J., Yan, Y., Wilson, K.S., White, M.A., Wright, W.E. & Shay, J.W. (1999). Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genetics, 21, 115118.
Muir, D.S. & Griffin, G.E. (2001). Infection risks in xenotransplantation — prepared for the Department of Health. Department of Health. www.doh.gov/ukxira.htm
Myint, S.H., Kilvington, S., Maggs, A., Swann, R.A. & Norman, R.I. (1999). Principles of infectious disease. In Medical microbiology made memorable. Churchill Livingstone.
National Heart Forum (1999). Looking to the future: making coronary heart disease an epidemic of the past. The Stationery Office, London.
O'Brien, C. (2003). The challenge of increased longevity for pension providers. Paper presented to the 25th U.K. Insurance Economists' Conference. Nottingham University Business School.
Oeppen, J. & Vaupel, J. (2002). Broken limits to life expectancy. Science, 296, 10291031.
Office of National Statistics (1997a). The health of adult Britain 1841-1994. H.M.S.O., London.
Office of National Statistics (1997b). Health inequalities. H.M.S.O., London.
Office of National Statistics (2002). Living in Britain: results from the 2001 General Household Survey. H.M.S.O., London.
Office of National Statistics (2003). Twentieth century mortality. H.M.S.O., London.
Olshansy, S.J., Hayflick, L. & Carnes, B.A. (2002). Position statement on human aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 57, B292B297.
Pawlotsky, J.M. (2003). Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Research, 59, 1, 111.
PHLS (2001). Antimicrobial resistance in 2000 in England and Wales.
PHLS (2003a). HIV infection and AIDS in the United Kingdom: monthly report - April 2003 (A survey of HIV infections diagnosed in 2002). CDR Weekly - 25 April 2003. 13, 17.
PHLS (2003b). HIV infection in women giving birth in the United Kingdom: trends in prevalence and proportions diagnosed to the end of June 2002. CDR Weekly - 27 March 2003. 13, 13.
PHLS (2003c). AIDS and HIV infection in the United Kingdom: monthly report - February 2003 (Analysis of end year HIV data: 2002). CDR Weekly - 20 February 2003. 13, 8.
PHLS (2003d). HIV and women in the U.K. CDR Weekly - 3 January 2003.
PHLS (2003e). Tuberculosis update March 2003.
Quinn, T.C. (2003). World AIDS day: reflection on the pandemic. The Hopkins HIV Report - January 2003.
Rodgers, A. (2003). A cure for cardiovascular disease? British Medical Journal, 326, 14071408.
Rota, P.A., Oberste, M.S., Monroe, S.S.et al. (2003). Characterization of a novel corornavirus associated with severe acute respiratory syndrome. Science, 300, 13941399.
Roth, G.S., Lane, M.A., Ingram, D.K., Mattison, J.A., Elahi, D., Tobin, J.D., Muller, D. & Metter, E.J. (2002). Biomarkers of caloric restriction may predict longevity in humans. Science, 297, 811.
Rubin, H. (1998). Telomerase and cellular lifespan: ending the debate? Nat Biotechnol., 16(5), 396397.
Rudolph, K.L., Chang, S., Millard, M., Schreiber-Agus, N. & DePinho, R.A. (2000). Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science, 287(5456), 12531258.
Shiels, P.G., Kind, A.J., Campbell, K.H., Waddington, D., Wilmot, I., Colman, A., & Schnieke, A.E. (1999). Analysis of telomere lengths in cloned sheep. Nature, 399(6734), 316317.
Sikora, K. (1999). Cancer survival in Britain. British Medical Journal, 319, 461462.
Smith, R. (2003). The most important BMJ for 50 years? British Medical Journal, 326.
Spencer, R.C. (2002). Deaths from MRSA. British Medical Journal, Rapid release - 17 December 2002.
Sze, M. & Rosenberg, M. (1998). Overview: impact of mortality improvement on social security in Canada, Mexico and the United States. North American Actuarial Journal, Vol. 2, No. 4, 83107.
Szutorisz, H., Lingner, J., Cuthbert, A.P., Trott, D.A., Newbold, R.F. & Nabholz, M. (2003). A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin. Cancer Res. 63(3), 689695.
Tabeau, E. (2001). A review of demographic forecasting models for mortality. In Forecasting mortality in developed countries. Edited by Tabeau, Ewa, Jeths, Anneke van den Berg and Heathcote, Christopher. Kluwer Academic Publishers.
Terajima, T., Yamagata, S., Satoh, N. & Ueda, S. (2003). Meta-analysis: effect of ACE inhibitors on outcomes in patients with renal insufficiency. The Pharmacy and Therapeutics Journal. Available at http://216.119.117.233/ptjournal/fulltext/28/2/PTJ2802098.pdf
Thatcher, A.R. (1999). The demography of centenarians in England & Wales. Population Trends, 96, 510.
Todd, W.T.A. & Dundas, S. (2001). The management of VTEC O157 infection. International Journal of Food Microbiology, 66, 103110.
Townsend, P. & Davidson, N. (1982). Inequalities in health: the Black report. Penguin Books.
Tuljapurkar, S. & Boe, C. (1998). Mortality change and forecasting: how much and how little do we know? North American Actuarial Journal, 2(4), 1347.
Turner, A. (2003). The macro-economics of pensions. Lecture to the actuarial profession, 2 September 2003.
Turner, N.J., Howard, R.A., Mulley, G.P. & Selby, P.J. (1999). Cancer in old age: is it inadequately investigated and treated? British Medical Journal, 319, 309312.
U.K. CJD Surveillance Unit (2003). CJD statistics - 4 July 2003. www.cjd.ed.ac.uk
UN AIDS & WHO (2002). AIDS epidemic update, December 2002. www.who.int
Valkonen, T. (2001). Trends in differential mortality in European countries. In Trends in mortality and differential mortality. Edited by Vallin, Jacques, Mesle, France & Valkonen, Tapani. Council of Europe Publishing, Strasbourg.
Vaupel, J. (1997). Trajectories of mortality at advanced ages. In Between Zeus and the salmon: the biodemography of longevity. Edited by Wachter, Kenneth and Finch, Caleb. National Academy Press, Washington.
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A.L., Orosz, L. & Muller, F. (2003). Influence of TOR kinase on lifespan in C. elegans. Nature, 426(6967), 620.
Wadsworth, M., Findlater, A. & Boardman, T. (2001). Reinventing annuities. Paper presented to the Staple Inn Actuarial Society.
Wadsworth, M. (2003). The future of the pension annuity market. Association of British Insurers.
Wald, N.J. & Law, M.R. (2003). A strategy to reduce cardiovascular disease by more than 80%. British Medical Journal, 326, 14191423.
White, C. (2003). ‘Polypill’ to fight cardiovascular disease: summary of rapid responses. British Medical Journal, 327, 809.
WHO (2000). Weekly epidemiological record, 12, 75, 93100. www.who.int/wer
WHO (2002). Life tables for 191 countries. World mortality in 2000. www.who.int
WHO (2003). Severe acute respiratory syndrome (SARS): status of the outbreak and lessons for the immediate future. Geneva 20 May 2003.www.who.int
Wilkie, A.D., Waters, H.R. & Yang, S.Y. (2003). Reserving, pricing and hedging for policies with guaranteed annuity options. British Actuarial Journal, 9, 263425 and 10, 101-152.
Willets, R.C. (1999). Mortality in the next millennium. Paper presented to the Staple Inn Actuarial Society.
Willets, R.C. (2003). The cohort effect: insights & explanations. British Actuarial Journal, 10, 833877.
Wilmot, J. & Lundstrom, H. (1996). Extreme longevity in five countries. European Journal of Population, 12(1). 6393.
Wilmoth, J.R. (1997). In search of limits. In Between Zeus and the salmon: the biodemography of longevity. Edited by Wachter, Kenneth & Finch, Caleb. National Academy Press. Washington D.C.
Yerly, S., Kaiser, L., Race, E., Bru, J.P., Chavel, F. & Perrin, L. (1999). Transmission of antiretroviral-drug-resistant HIV-1 variants. The Lancet, 354, 729733.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed